Delayed Diagnostic Time& Inflammatory Bowel Diseased Patients

NCT ID: NCT04952558

Last Updated: 2021-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

700 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-01

Study Completion Date

2022-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction The incidence of inflammatory bowel disease \[IBD\] is increasing worldwide. Both Crohn's disease \[CD\] and ulcerative colitis \[UC\] are therefore becoming an important public health issue\[1\] The IBD is characterized by chronic intestinal inflammation, which can cause bowel damage and intestinal complications primarily depending on the duration and severity of the inflammation\[2\] The diagnosis of inflammatory bowel diseases (IBD) is often established following considerable delay due to nonspecific and inconsistent symptoms. In previous western studies, the delayed diagnosis was associated with poor outcome in patients with Crohn's disease (CD).\[2\] Timely diagnosis is not only important for the patients themselves but has also become a relevant public health issue due to the rising incidence of IBD worldwide\[3\] Patients and methods Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions Aim of the study

1. Estimate time delay for diagnosis of Egyptian inflammatory bowel diseased patients
2. compare the delay time for diagnosis of Egyptian inflammatory bowel diseased patients globally

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

diagnostic Lag time among Egyptian inflammatory bowel diseased patients

Introduction The incidence of inflammatory bowel disease \[IBD\] is increasing worldwide. Both Crohn's disease \[CD\] and ulcerative colitis \[UC\] are therefore becoming an important public health issue\[1\] The IBD is characterized by chronic intestinal inflammation, which can cause bowel damage and intestinal complications primarily depending on the duration and severity of the inflammation\[2\] The diagnosis of inflammatory bowel diseases (IBD) is often established following considerable delay due to nonspecific and inconsistent symptoms. In previous western studies, the delayed diagnosis was associated with poor outcome in patients with Crohn's disease (CD).\[2\] Timely diagnosis is not only important for the patients themselves but has also become a relevant public health issue due to the rising incidence of IBD worldwide\[3\] Abdominal pain is the most prevalent initial chief complaint in patients with CD; however, it is also a common symptom of other digestive disorders, such as irritable bowel syndrome may the pain is not severe, it is easily regarded as trivial, and the diagnosis may be missed because the tests needed for the diagnosis of IBD are not performed. \[4\] A delayed diagnosis of CD may incur high medical cost in patients who develop aggressive disease that requires treatment with anti-TNFα agents\[5\] Aim of the study

1. Estimate time delay for diagnosis of Egyptian inflammatory bowel diseased patients
2. compare the delay time for diagnosis of Egyptian inflammatory bowel diseased patients globally
3. studing risk factors that causing diagnostic delay among Egyptian inflammatory bowel diseased patients the time
4. frequency of diagnosed complicated inflammatory bowel diseased as first time presentation

Patients and methods Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions

Inclusion criteria Egyptian inflammatory bowel diseased patients above the age of 18 years with definite diagnosis based on clinical ,endoscopic ,histological basis

Detailed history will be taken from all included patients focus on

* age ,sex , special habit ,residence .
* education level -socioeconomic status
* type of the inflammatory bowel disease
* lag time for reaching the proper diagnosis of inflammatory bowel disease which definite as time from the first symptoms presentation to reaching definite diagnosis
* symptoms that causing patients seeking medical advice
* number of Inflammatory bowel diseased patients referred for first time from surgeons
* number of patients have perianal symptoms
* number of patients have previous history of appendicectomy
* physicians numbers that visited by the patients to reaching the diagnosis
* ileal intubation at first time colonoscopy
* number of patients change their diagnosis from ulcerative colitis to Crohn's disease
* type of radiological assessment of the examined patients

Exclusion criteria Inflammatory bowel diseased Patients below 18 years old

Ethical consideration:

consent will be taken from all participating patients and must be approved by the ethical committee

References :

1. E. V. Loftus, "Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences," Gastroenterology, vol. 126, no. 6, pp. 1504-1517, 2004, doi: 10.1053/j.gastro.2004.01.063.
2. D. W. Lee et al., "Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery," World J. Gastroenterol., vol. 23, no. 35, pp. 6474-6481, Sep. 2017, doi: 10.3748/wjg.v23.i35.6474.
3. S. R. Vavricka et al., "Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease," Inflamm. Bowel Dis., vol. 18, no. 3, pp. 496-505, Mar. 2012, doi: 10.1002/ibd.21719.
4. G. Novacek et al., "Diagnostic delay in patients with inflammatory bowel disease in Austria," Wien. Klin. Wochenschr., vol. 131, no. 5-6, pp. 104-112, Mar. 2019, doi: 10.1007/s00508-019-1451-3.
5. L. Cantoro et al., "The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study," J. Crohn's Colitis, vol. 11, no. 8, pp. 975-980, Aug. 2017, doi: 10.1093/ecco-jcc/jjx041.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cross sectional observational study

Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions

Detailed history will be taken from all included patients focus on

* age ,sex , special habit ,residence .
* education level -socioeconomic status
* type of the inflammatory bowel disease
* lag time for reaching the proper diagnosis of inflammatory bowel disease which definite as time from the first symptoms presentation to reaching definite diagnosis
* symptoms that causing patients seeking medical advice
* number of Inflammatory bowel diseased patients referred for first time from surgeons
* number of patients have perianal symptoms
* number of patients have previous history of appendicectomy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Egyptian inflammatory bowel diseased patients above the age of 18 years with definite diagnosis based on clinical ,endoscopic ,histological basis

\-

Exclusion Criteria

Inflammatory bowel diseased Patients below 18 years old

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bahaa osman taha

assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bahaa Osman Taha

Asyut, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

bahaa M taha, MD

Role: CONTACT

0201015599135 ext. ASSIUT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

BAHAA OS TAHA, MD

Role: primary

0201015599135

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ESIBD1989BAHAA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.